MENU
AUPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aurinia Pharmaceuticals (AUPH) Ownership - Who owns Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.5B
P/E Ratio
26.44
Total Cash
315.13M
Projected Growth
N/A
Total Debt
81.83M
Revenue
260.11M
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash/Share
2.39
Total Debt/Equity
N/A
Revenue/Share
1.80 USD as % of share price
Fundamentals
AUPH
Capitalization
1.5B
P/E Ratio
26.44
Risk (Beta)
1.59
Dividend Yield
N/A
Total Cash
315M
Total Cash/Share
2.39
Total Debt
81.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.80%
Revenue
260M
ROE
N/A
Book Value
335M
P/B Ratio
4.46
Cash Flow
N/A
Earnings
0.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.12B
Current Ratio
5.23
Current Revenue Per Employee
233360.00
Dividends Per Share - Security
N/A
EBITDA
86.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
89.84
Revenue To Assets
11.82
Shares Held By Institutions
681M
Shares Outstanding - Current
132M
Total Liabilities
167M
Total Volume MTD
N/A
Value
-1
Gain YTD
26.615
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AUPH showed earnings on July 31, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com